ESR1 Mutations in Metastatic Breast Cancer
Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial
lystn.fm © 2025.
ALL RIGHTS RESERVED. CONTENT IS COPYRIGHT OF RESPECTIVE CONTENT OWNERS.
ALL RIGHTS RESERVED. CONTENT IS COPYRIGHT OF RESPECTIVE CONTENT OWNERS.